• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奇数跳跃相关 1 通过促进卵泡抑素样蛋白 1 转录在卵巢癌中发挥肿瘤抑制作用。

Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.

机构信息

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, Liaoning, China.

出版信息

Hum Cell. 2022 Nov;35(6):1824-1837. doi: 10.1007/s13577-022-00767-5. Epub 2022 Aug 14.

DOI:10.1007/s13577-022-00767-5
PMID:35964260
Abstract

Zinc-finger transcription factor odd-skipped related 1 (OSR1) is involved in the progression of certain types of cancers, via regulating the transcription of downstream genes. However, the function of OSR1 in ovarian cancer (OC) progression remains unclear. The present study aimed to explore the OSR1 expression pattern in OC tissues and cell lines. Functional assays were performed to explore the regulatory effects of OSR1 on OC cell growth, migration and invasion in vitro and in vivo. Results of the present study demonstrated that OSR1 was significantly downregulated in OC tissues compared with healthy ovarian tissues (P < 0.01). Moreover, SKOV-3 and OVCAR-3 cells with low OSR1 expression were used for functional studies, and results demonstrated that OSR1 overexpression suppressed cell growth by inhibiting cell cycle progression and inducing cell apoptosis in vitro. OC cells with higher OSR1 expression levels exhibited reduced levels of migration and invasion, when compared with the corresponding control. In addition, OSR1 expression in xenografts models resulted in diminished tumor volume and suppressed tumorigenesis. OSR1 enhanced follistatin-like protein 1 (FSTL1) expression at the transcriptional level through directly binding to the promoter of FSTL1, which was commonly reported to exert a tumor suppressor role in OC progression. Moreover, FSTL1 knockdown reversed the action of OSR1 overexpression in OC progression, including cell viability, migration, invasion, and apoptosis. In conclusion, these results indicated that OSR1 may function as a tumor suppressor through augmenting FSTL1 transcription in OC progression, suggesting that the OSR1/ FSTL1 axis may exhibit potential as a therapeutic target for OC therapy.

摘要

锌指转录因子 odd-skipped 相关 1(OSR1)通过调节下游基因的转录参与某些类型癌症的进展。然而,OSR1 在卵巢癌(OC)进展中的作用尚不清楚。本研究旨在探讨 OSR1 在 OC 组织和细胞系中的表达模式。进行功能测定以探讨 OSR1 对 OC 细胞体外和体内生长、迁移和侵袭的调节作用。本研究结果表明,OSR1 在 OC 组织中的表达明显低于健康卵巢组织(P<0.01)。此外,使用低 OSR1 表达的 SKOV-3 和 OVCAR-3 细胞进行功能研究,结果表明 OSR1 过表达通过抑制细胞周期进程和诱导细胞凋亡来抑制体外细胞生长。与相应对照相比,OSR1 表达水平较高的 OC 细胞的迁移和侵袭水平降低。此外,异种移植模型中的 OSR1 表达导致肿瘤体积减小并抑制肿瘤发生。OSR1 通过直接结合 FSTL1 启动子在转录水平上增强卵泡抑素样蛋白 1(FSTL1)的表达,FSTL1 通常被报道在 OC 进展中发挥肿瘤抑制作用。此外,FSTL1 敲低逆转了 OSR1 过表达在 OC 进展中的作用,包括细胞活力、迁移、侵袭和凋亡。总之,这些结果表明,OSR1 可能通过增强 OC 进展中的 FSTL1 转录来发挥肿瘤抑制作用,这表明 OSR1/FSTL1 轴可能作为 OC 治疗的潜在治疗靶点。

相似文献

1
Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.奇数跳跃相关 1 通过促进卵泡抑素样蛋白 1 转录在卵巢癌中发挥肿瘤抑制作用。
Hum Cell. 2022 Nov;35(6):1824-1837. doi: 10.1007/s13577-022-00767-5. Epub 2022 Aug 14.
2
OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer.OSR1下调表明卵巢癌预后不良并激活核因子κB通路。
Discov Oncol. 2023 Aug 29;14(1):159. doi: 10.1007/s12672-023-00778-0.
3
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.长链非编码 RNA MNX1-AS1 通过靶向 miR-744-5p/SOX12 轴促进卵巢癌细胞进程。
J Ovarian Res. 2021 Nov 17;14(1):161. doi: 10.1186/s13048-021-00910-0.
4
Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.奇跳相关蛋白1是一种新型肿瘤抑制基因,也是胃癌潜在的预后生物标志物。
J Pathol. 2014 Nov;234(3):302-15. doi: 10.1002/path.4391. Epub 2014 Aug 28.
5
FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.FSTL1 抑制非小细胞肺癌肿瘤细胞的增殖、侵袭和存活。
Oncol Rep. 2018 Jan;39(1):13-20. doi: 10.3892/or.2017.6061. Epub 2017 Oct 31.
6
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.卵泡抑素样蛋白1在透明细胞肾细胞癌中发挥肿瘤抑制作用。
Chin J Cancer. 2018 Jan 22;37(1):2. doi: 10.1186/s40880-018-0267-2.
7
Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.长链非编码 RNA FEZF1-AS1 通过调控 miR-130a-5p/SOX4 轴促进卵巢癌细胞的进展。
J Cell Mol Med. 2020 Apr;24(7):4275-4285. doi: 10.1111/jcmm.15088. Epub 2020 Mar 5.
8
Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer.分析在宫颈癌中卵泡抑素样蛋白 1 的表达和作用机制。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8652. Epub 2023 Oct 27.
9
Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.卵泡抑素样蛋白1在卵巢癌和子宫内膜癌发生中的肿瘤抑制作用:差异表达及功能分析
Carcinogenesis. 2009 Jan;30(1):114-21. doi: 10.1093/carcin/bgn215. Epub 2008 Sep 16.
10
Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription.miR-1246 沉默通过促进 ZNF23 转录诱导顺铂耐药卵巢癌细胞周期停滞和凋亡。
Cytogenet Genome Res. 2021;161(10-11):488-500. doi: 10.1159/000520069. Epub 2021 Dec 17.

引用本文的文献

1
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.MexTAg协作杂交系:宿主基因影响石棉相关疾病的潜伏期,但肿瘤发生后影响较小。
Front Toxicol. 2024 Apr 17;6:1373003. doi: 10.3389/ftox.2024.1373003. eCollection 2024.
2
Expression of the Gene in .该基因在……中的表达。
MicroPubl Biol. 2023 Aug 25;2023. doi: 10.17912/micropub.biology.000967. eCollection 2023.
3
OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer.

本文引用的文献

1
FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.活化的成纤维细胞分泌的 FSTL1 促进肝癌转移和干性。
Cancer Res. 2021 Nov 15;81(22):5692-5705. doi: 10.1158/0008-5472.CAN-20-4226. Epub 2021 Sep 22.
2
Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.鉴定一个与肿瘤微环境相关的七基因标志物,用于预测膀胱癌的预后。
BMC Cancer. 2021 Jun 10;21(1):692. doi: 10.1186/s12885-021-08447-7.
3
FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival.
OSR1下调表明卵巢癌预后不良并激活核因子κB通路。
Discov Oncol. 2023 Aug 29;14(1):159. doi: 10.1007/s12672-023-00778-0.
FSTL1通过激活AKT相关通路促进胃癌的生长和转移,并预示着较差的生存率。
Am J Cancer Res. 2021 Mar 1;11(3):712-728. eCollection 2021.
4
FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.FSTL1 通过抑制 NF-κB 通路增加上皮性卵巢癌细胞对顺铂的敏感性。
Cancer Chemother Pharmacol. 2021 Mar;87(3):405-414. doi: 10.1007/s00280-020-04215-9. Epub 2021 Jan 3.
5
Reduced expression of odd-skipped related transcription factor 1 promotes proliferation and invasion of breast cancer cells and indicates poor patient prognosis.odd-skipped相关转录因子1表达降低促进乳腺癌细胞增殖和侵袭,并提示患者预后不良。
Oncol Lett. 2020 Sep;20(3):2946-2954. doi: 10.3892/ol.2020.11820. Epub 2020 Jul 7.
6
Downregulation of OSR1 Promotes Colon Adenocarcinoma Progression via FAK-Mediated Akt and MAPK Signaling.OSR1的下调通过FAK介导的Akt和MAPK信号促进结肠腺癌进展。
Onco Targets Ther. 2020 Apr 24;13:3489-3500. doi: 10.2147/OTT.S242386. eCollection 2020.
7
Exploring cisplatin resistance in ovarian cancer through integrated bioinformatics approach and overcoming chemoresistance with sanguinarine.通过综合生物信息学方法探索卵巢癌中的顺铂耐药性并使用血根碱克服化疗耐药性。
Am J Transl Res. 2020 Mar 15;12(3):923-939. eCollection 2020.
8
Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.卵泡抑素样蛋白 1 通过抑制骨桥蛋白的蛋白水解激活来抑制肺癌转移。
Cancer Res. 2019 Dec 15;79(24):6113-6125. doi: 10.1158/0008-5472.CAN-19-0842. Epub 2019 Oct 25.
9
Epithelial ovarian cancer: Evolution of management in the era of precision medicine.上皮性卵巢癌:精准医学时代的治疗进展。
CA Cancer J Clin. 2019 Jul;69(4):280-304. doi: 10.3322/caac.21559. Epub 2019 May 17.
10
Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39].《“Odd-skipped相关转录因子1(OSR1)通过抑制NF-κB途径抑制舌鳞状细胞癌的迁移和侵袭”的勘误》[《欧洲药理学杂志》15(2018年)33 - 39页]
Eur J Pharmacol. 2019 Mar 15;847:158. doi: 10.1016/j.ejphar.2018.11.042. Epub 2018 Dec 7.